MK0991
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK0991, covering 2015-01-13 to 2017-02-23. Get the full timeline:
Most recent: Clinical Trial Update: MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) [Phase 2]